InvestorsHub Logo
Followers 48
Posts 5518
Boards Moderated 0
Alias Born 09/04/2009

Re: jessellivermore post# 21576

Thursday, 11/14/2013 4:29:05 PM

Thursday, November 14, 2013 4:29:05 PM

Post# of 426487
Eric Coleman said PCSK9 inhibitors will not need outcome study. Double standard?

http://www.bloomberg.com/news/2013-11-14/amgen-and-sanofi-pcsk9-drugs-can-reach-u-s-without-long-studies.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News